Lacktman, Wein Discuss New Telehealth Reimbursement Codes
November 12, 2019
mHealth Intelligence
Partner Nate Lacktman and Of Counsel Emily Wein were quoted in an mHealth Intelligence article, “CMS Expands Telehealth Coverage for Opioid Abuse Disorder Treatment,” about the adoption of new reimbursement codes that will allow providers to bill Medicare for telehealth services to treat opioid abuse, including care delivered to the home.
Lacktman and Wein, writing in a blog post, said the new codes, combined with recent legislation removing geographic limitations for telehealth services to individuals diagnosed with a substance abuse disorder, will provide new opportunities to deliver care to the patient’s home. “No originating site facility fee is paid when the beneficiary’s home is the originating site,” they wrote.
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."